Oncolytics Biotech Inc.
|
|||
| Mailing Address: | Suite 210, 1167 Kensington Crescent NW Calgary, Alberta T2N 1X7 |
Head Office Address: | Suite 210, 1167 Kensington Crescent NW Calgary, Alberta T2N 1X7 |
| Contact Name: | Kirk Look | Principal Regulator: | Alberta |
| Business e-mail address: | info@oncolyticsbiotech.com | Short Form Prospectus Issuer: | Yes |
| Telephone Number: | 403 670-7377 | Reporting Jurisdictions: | British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, Quebec, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland, North West Territories, Yukon, Nunavut |
| Fax Number: | 403 283-0858 | Stock Exchange: | TSX |
| Date of Formation: | Apr 2 1998 | Stock Symbol: | ONC |
| Jurisdiction Where Formed: | Alberta | Auditor: | Ernst & Young |
| Industry Classification: | consumer products - biotechnology/pharmaceuticals | General Partner: | |
| CUSIP Number: | 682310 | Transfer Agent: | Computershare Trust Company of Canada |
| Financial Year-End: | Dec 31 | Size of Issuer (Assets): | $25,000,001 to $100,000,000 |
|
